Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
Recruiting · NCT07242638 · Registry updated 2026-02-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Down syndrome, Hypersensitivity, Immediate, Neurobehavioral Manifestations, Neurologic Manifestations, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, alopecia, alopecia areata, atopic eczema, chromosomal disorder, dermatitis, disorder of pilosebaceous unit, hereditary disease, hereditary skin disorder, hypotrichosis, immune system disorder, intellectual disability, nervous system disorder, skin disorder | Recruiting | Phase 2 | 2026-02-02 | NCT07242638 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Columbia University | 375 |
| Icahn School of Medicine at Mount Sinai | 256 |
| National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 108 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |